A business in context

RGBP research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001493152-26-038576

  2. 8-K · Current report

    Report date 2026-07-10 · 0001493152-26-033364 · Items 1.01,4.01,8.01,9.01

  3. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-022924

  4. 8-K · Current report

    Report date 2026-02-04 · 0001493152-26-008837 · Items 3.02

  5. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001493152-26-006526

  6. 8-K · Current report

    Report date 2026-01-15 · 0001493152-26-004733 · Items 3.02

  7. 8-K · Current report

    Report date 2026-01-19 · 0001493152-26-002956 · Items 8.01

  8. 10-K · Annual report

    Report date 2025-09-30 · 0001493152-25-029526

  9. 8-K · Current report

    Report date 2025-10-08 · 0001493152-25-022185 · Items 3.02

  10. 8-K · Current report

    Report date 2025-10-02 · 0001493152-25-016767 · Items 1.01,3.02,8.01,9.01

  11. 8-K · Current report

    Report date 2025-09-15 · 0001493152-25-014182 · Items 3.02

  12. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001641172-25-022884

  13. 8-K · Current report

    Report date 2025-08-05 · 0001641172-25-022575 · Items 1.01,3.02,9.01

  14. 8-K · Current report

    Report date 2025-07-28 · 0001641172-25-021882 · Items 1.01,3.02,9.01

  15. 8-K · Current report

    Report date 2025-06-10 · 0001641172-25-014652 · Items 3.02,9.01

  16. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641172-25-012619

  17. 10-Q · Quarterly report

    Report date 2024-12-31 · 0001641172-25-011206

  18. 10-K · Annual report

    Report date 2024-09-30 · 0001641172-25-009968

  19. 8-K · Current report

    Report date 2025-05-13 · 0001641172-25-009967 · Items 4.02

  20. 8-K · Current report

    Report date 2025-03-31 · 0001641172-25-002908 · Items 4.01

  21. 8-K · Current report

    Report date 2024-09-30 · 0001493152-24-048090 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2024-09-18 · 0001493152-24-037011 · Items 8.01

  23. 8-K · Current report

    Report date 2024-09-04 · 0001493152-24-036161 · Items 1.01,9.01

  24. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001607062-24-000238

  25. 8-K · Current report

    Report date 2024-05-28 · 0001607062-24-000219 · Items 4.01

  26. 8-K · Current report

    Report date 2024-05-20 · 0001607062-24-000211 · Items 5.03,8.01,9.01

  27. 8-K · Current report

    Report date 2024-05-10 · 0001607062-24-000175 · Items 4.01

  28. 8-K · Current report

    Report date 2024-04-26 · 0001607062-24-000150 · Items 1.01,3.02,8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001607062-24-000131

  30. 8-K · Current report

    Report date 2024-02-07 · 0001607062-24-000053 · Items 8.01

  31. 10-Q · Quarterly report

    Report date 2023-12-31 · 0001607062-24-000033

  32. 10-K · Annual report

    Report date 2023-09-30 · 0001607062-23-000524

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001589150Regen BioPharma Inc

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2025-09-30$236.6K$249.1K
    2024-09-30$236.6K$255.8K
    2023-09-30$236.6K$263.7K

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗